NCT00003595 - Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

April 30, 2006

Conditions

Lymphoma

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

rituximab

DRUG

CHOP regimen

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (13)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10021

Memorial Sloan-Kettering Cancer Center, New York

10029

Mount Sinai School of Medicine, New York

10032

Herbert Irving Comprehensive Cancer Center, New York

33136

Sylvester Cancer Center, University of Miami, Miami

94110

San Francisco General Hospital Medical Center, San Francisco

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

02114-2617

Massachusetts General Hospital, Boston

07103

University Hospital/New Jersey Cancer Center, Newark

44106-5065

Ireland Cancer Center, Cleveland

43210-1240

Arthur G. James Cancer Hospital - Ohio State University, Columbus

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH